New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-sma
Phase III FLAURA trial demonstrates 52% risk reduction of CNS disease progre...
2017-11-21
文传商讯
Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-
Phase I/II trial findings add to growing body of data on acalabrutinib clini...
2016-12-06
文传商讯
